McCurdy, S., Keedy, K., Lawrence, L., Nenninger, A., Sheets, A., Quintas, M., & Cammarata, S. (2020). Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial. Antimicrob Agents Chemother.
Citação norma ChicagoMcCurdy, Sandra, Kara Keedy, Laura Lawrence, Ashley Nenninger, Amanda Sheets, Megan Quintas, and Sue Cammarata. "Efficacy of Delafloxacin Versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults With Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results From the Delafloxacin Phase 3 CABP Trial." Antimicrob Agents Chemother 2020.
ציטוט MLAMcCurdy, Sandra, et al. "Efficacy of Delafloxacin Versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults With Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results From the Delafloxacin Phase 3 CABP Trial." Antimicrob Agents Chemother 2020.